Anyone else got tickets?
You might still have time tomorrow morning before all the market makers update their valuations.
https://vimeo.com/143549131
http://asteriasbiotherapeutics.com/inv_news_listings.php?listing=1589&#asteriasNews
>>1755451
Is this real or just a meme?
>>1755451
It's real man,
https://stemcell.usc.edu/2016/09/07/paralyzed-man-regains-use-of-arms-and-hands-after-experimental-stem-cell-therapy-at-keck-hospital-of-usc/
>>1755479
I'm seeing a lot of resistance around the $5 mark. I have $3000 to invest tomorrow, but I hesistant to think this can break $5.30 before crashing again to the mid $4 mark.
What are your portfolio returns like?
>>1755481
Lol, I doubt you can buy it before $6
Can very well go beyond double tomorrow.
Well let's see, I bought NVDA at $39, MU at 10, increased at 18 before last earnings, at $pgnx at 5.2.
I even told you guys about $omer once, you still have some time on that one. I'm moved in big to lots of bios, but no names till I'm done.
>>1755479
>at-keck-hospital-of-usc
>kek hospital
I can't get this shit serious anon, I'm sorry
what should i sell at
>>1755493
What's to get? They inject stem cell derived OPC cells after the injury, and those cells remyelinate the axons in the spinal cord, and thus the patient recovers more function.
>>1755496
Well do the math. ~2 billion in peak year revenue, say 1billion earnings, so market cap ~ 15 Billion.
Clearly enough good data to move to phase three, risk adjust by half, so 7.5 billion. Say that takes 5 years to reach, so net present value is 2.1 Billion. Current market cap is 229 million....
So you should sell it at about $50 per share, before any dilution. So maybe take 30% dilution for warrants and such. So maybe $35 a share, but you should keep track of the actually number as time goes on...